- In May 2023, Argon Medical Devices introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument, a new addition to the biopsy needle market. This innovative device aims to improve biopsy procedures with enhanced efficiency and precision, potentially offering healthcare professionals advanced tools to enhance diagnostic accuracy and patient outcomes
- In April 2021, AprioMed extended its collaboration with Cenova, aiming to bolster its foothold in the South American market. This strategic alliance may enhance their presence and offerings in the breast biopsy needle market, potentially enabling AprioMed to capitalize on emerging opportunities and meet the region's healthcare needs more effectively
- In February 2021, Hologic Inc's acquisition of biotheranostics marked their entry into the expanding oncology market, including breast cancer. This strategic move enhances their network and capabilities in cancer diagnostics, potentially benefiting their offerings in the breast biopsy needle market through increased innovation and market presence
